Discover and read the best of Twitter Threads about #HFA_ESC
Most recents (7)
📌#HeartFailure2023 #HFA_ESC ¿De qué se está hablando en Praga🇨🇿? Parte 2⃣.
💡Aquí info seleccionada de la cobertura & publicaciones de @WilfriedMullens @HanCardiomd @escardio
🔸Comenzamos:
📌STRONG-HF: subanálisis segun eGFR y edad..
#CardioTwitter #MedTwitter #CVD
💡Aquí info seleccionada de la cobertura & publicaciones de @WilfriedMullens @HanCardiomd @escardio
🔸Comenzamos:
📌STRONG-HF: subanálisis segun eGFR y edad..
#CardioTwitter #MedTwitter #CVD
📌ENACT-HF: terapia guiada por natriuresis🧂💦
📌PARADISE: Camino del pte con disnea en ER🏥.
📌#HeartFailure2023 #HFA_ESC ¿De qué se está hablando en Praga🇨🇿? @escardio
Aquí links a tweets y muchas novedades seleccionadas.
💡Comenzamos con el #PARAGLIDE-HF
sciencedirect.com/science/articl…
Aquí links a tweets y muchas novedades seleccionadas.
💡Comenzamos con el #PARAGLIDE-HF
sciencedirect.com/science/articl…
🎙️@WilfriedMullens entrevista a @hvanspall
& Jasper Brugts presentando los datos del #PARAGLIDE
🎙️Mas del #PARAGLIDE, implicancias en el tratamiento de la IC. Brenda Mora & @robmentz
traen un resumen, entrevistados por @ARakisheva
& Jasper Brugts presentando los datos del #PARAGLIDE
🎙️Mas del #PARAGLIDE, implicancias en el tratamiento de la IC. Brenda Mora & @robmentz
traen un resumen, entrevistados por @ARakisheva
📌#MONITOR-HF trial
✅La monitorización remota de las presiones pulmonares mejora la calidad de vida (QOL) y⬇️🏥por IC.
🔸25🏥🇳🇱👉RCT 348👥a CardioMEMS-HF device🆚 control.
🔹69a, FEVI 30% (23–40%)
thelancet.com/journals/lance…
templehealth.org/about/blog/car…
✅La monitorización remota de las presiones pulmonares mejora la calidad de vida (QOL) y⬇️🏥por IC.
🔸25🏥🇳🇱👉RCT 348👥a CardioMEMS-HF device🆚 control.
🔹69a, FEVI 30% (23–40%)
thelancet.com/journals/lance…
templehealth.org/about/blog/car…
#HFA_ESC @escardio scientific updates
Patient profiling in HFpEF
What are therapeutic options for #HFpEF in 2023 ?
#HeartFailure2023 @NicolasGirerd @DrMarthaGulati @Marta33717088 @LauraMeems @CharlesFauvel @Giccardio_fr @HFA_President @WilfriedMullens @escardio
Patient profiling in HFpEF
What are therapeutic options for #HFpEF in 2023 ?
#HeartFailure2023 @NicolasGirerd @DrMarthaGulati @Marta33717088 @LauraMeems @CharlesFauvel @Giccardio_fr @HFA_President @WilfriedMullens @escardio
Numbers of emerging treatments are under investigation for HFpEF
#HeartFailure2023 @markcpetrie20 @DrMarthaGulati @Marta33717088 @LauraMeems @CharlesFauvel @Giccardio_fr @HFA_President @WilfriedMullens
#HeartFailure2023 @markcpetrie20 @DrMarthaGulati @Marta33717088 @LauraMeems @CharlesFauvel @Giccardio_fr @HFA_President @WilfriedMullens
📍#SGLT2i should be initiated in all HFpEF patients without contraindications, ideally once stable during hospitalization for index event.
#HeartFailure2023 @MarcoMetra @HFA_President @WilfriedMullens
#HeartFailure2023 @MarcoMetra @HFA_President @WilfriedMullens
Results of the randomized #ADVOR trial are soon coming your way! It's the largest diuretic trial in acute #heartfailure ever conducted (N=519) and will test acetazolamide on top of loop diuretics. Recruitment is finished and full database lock is anticipated. Find out more (1/9).
Appropriate and thorough decongestion is class I recommendation in HFA-ESC guidelines (2/9).
academic.oup.com/eurheartj/arti…
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
academic.oup.com/eurheartj/arti…
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
Only 15% of AHF included in DOSE trial were decongested after 72 hours of high-dose loop diuretic (LD) therapy (3/9).
nejm.org/doi/full/10.10…
nejm.org/doi/full/10.10…
What to do if the eGFR drops from 50 to 42 ml/min/m2 during decongestive therapy in acute #HeartFailure ?
Short #Tweetorial on worsening renal function (WRF) (1/9).
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
Short #Tweetorial on worsening renal function (WRF) (1/9).
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
There is an underappreciated risk of poor outcome in heart failure patients discharged with ongoing congestion and WRF (2/9).
Pivotal paper of @MarcoMetra ahajournals.org/doi/10.1161/ci…
Pivotal paper of @MarcoMetra ahajournals.org/doi/10.1161/ci…
Appropriate and thorough decongestion is class I recommendation in HFA-ESC guidelines so DON'T stop decongestive efforts during WRF (3/9).
academic.oup.com/eurheartj/arti…
academic.oup.com/eurheartj/arti…
Which statement is correct with regards to the use of diuretics in #HeartFailure with congestion?
Short #Tweetorial on how to use diuretics in heart failure (1/9).
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
Short #Tweetorial on how to use diuretics in heart failure (1/9).
#Cardiotwitter #Cardiology #FOAMed #Cardiorenal #MedEd #MedTwitter #Nephrology #ADVOR #HeartFailure2022 #HFA_ESC
Door to ‘diuretic’ time: earlier administration of loop diuretics is associated with improved outcomes independent of HF severity (2/9).
jacc.org/doi/abs/10.101…
jacc.org/doi/abs/10.101…
The first dose of the loop diuretic should be 40 mg furosemide (=1 mg bumetanide) in diuretic naïve and twice the home dose in patients on loop diuretic (3/9).
